163 related articles for article (PubMed ID: 26825878)
1. Comparative Evaluation of Liposomal Albendazole and Tablet-Albendazole Against Hepatic Cystic Echinococcosis: A Non-Randomized Clinical Trial.
Li H; Song T; Shao Y; Aili T; Ahan A; Wen H
Medicine (Baltimore); 2016 Jan; 95(4):e2237. PubMed ID: 26825878
[TBL] [Abstract][Full Text] [Related]
2. [Clinical effect and safety of liposomal-albendazole and tablet-albendazole for the treatment of human cystic echinococcosis].
Li HT; Shan JY; Shao YM; Tuergan A; Ayifuhan A; Ran B; Wen H
Zhonghua Gan Zang Bing Za Zhi; 2011 Jul; 19(7):532-6. PubMed ID: 22152246
[TBL] [Abstract][Full Text] [Related]
3. Albendazole chemotherapy for human cystic and alveolar echinococcosis in north-western China.
Wen H; Zou PF; Yang WG; Lu J; Wang YH; Zhang JH; New RR; Craig PS
Trans R Soc Trop Med Hyg; 1994; 88(3):340-3. PubMed ID: 7974683
[TBL] [Abstract][Full Text] [Related]
4. Effects of albendazole nanoparticles in mice with hepatic echinococosis: Portal vein cannulation versus intravenous administration.
Zhu DW; Zhang MX; Bao YJ; Gu JP; Ji WZ; Zhang HX; Ren WX
Exp Parasitol; 2015 Jul; 154():43-6. PubMed ID: 25891538
[TBL] [Abstract][Full Text] [Related]
5. Comparative performances of flubendazole and albendazole in cystic echinococcosis: ex vivo activity, plasma/cyst disposition, and efficacy in infected mice.
Ceballos L; Elissondo C; Sánchez Bruni S; Denegri G; Lanusse C; Alvarez L
Antimicrob Agents Chemother; 2011 Dec; 55(12):5861-7. PubMed ID: 21930885
[TBL] [Abstract][Full Text] [Related]
6. Post-treatment follow-up study of abdominal cystic echinococcosis in tibetan communities of northwest Sichuan Province, China.
Li T; Ito A; Pengcuo R; Sako Y; Chen X; Qiu D; Xiao N; Craig PS
PLoS Negl Trop Dis; 2011 Oct; 5(10):e1364. PubMed ID: 22039558
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Albendazole-Chitosan Microsphere-based Treatment for Alveolar Echinococcosis in Mice.
Abulaihaiti M; Wu XW; Qiao L; Lv HL; Zhang HW; Aduwayi N; Wang YJ; Wang XC; Peng XY
PLoS Negl Trop Dis; 2015; 9(9):e0003950. PubMed ID: 26352932
[TBL] [Abstract][Full Text] [Related]
8. Comparison of local ablation with Albendazole or laparoscopic hepatectomy combined with Albendazole in the treatment of early hepatic alveolar echinococcosis.
A J; Chai J; Shao Z; Zhao S; Wang H; A X; Yang J
Front Public Health; 2022; 10():960635. PubMed ID: 36276387
[TBL] [Abstract][Full Text] [Related]
9. A preventive effect of the combination of albendazole and pomegranate peel aqueous extract treatment in cystic echinococcosis mice model: An alternative approach.
Labsi M; Soufli I; Khelifi L; Amir ZC; Touil-Boukoffa C
Acta Trop; 2019 Sep; 197():105050. PubMed ID: 31170379
[TBL] [Abstract][Full Text] [Related]
10. Observations on clinical efficacy of albendazole emulsion in 264 cases of hepatic cystic echinococcosis.
Chai J; Menghebat ; Wei J; Deyu S; Bin L; Jincao S; Chen F; Xiong L; Yiding M; Xiuling W; Dolikun ; Guliber ; Yanchun W; Fanghua G; Shuhua X
Parasitol Int; 2004 Mar; 53(1):3-10. PubMed ID: 14984830
[TBL] [Abstract][Full Text] [Related]
11. Efficiency of liposomal albendazole for the treatment of the patients with complex alveolar echinococcosis: a comparative analysis of CEUS, CT, and PET/CT.
Li H; Song T; Qin Y; Liu W; Li X; Shao Y; Wen H
Parasitol Res; 2015 Nov; 114(11):4175-80. PubMed ID: 26239800
[TBL] [Abstract][Full Text] [Related]
12. Medical treatment versus "Watch and Wait" in the clinical management of CE3b echinococcal cysts of the liver.
Rinaldi F; De Silvestri A; Tamarozzi F; Cattaneo F; Lissandrin R; Brunetti E
BMC Infect Dis; 2014 Sep; 14():492. PubMed ID: 25204575
[TBL] [Abstract][Full Text] [Related]
13. Albendazole-lipid nanocapsules: Optimization, characterization and chemoprophylactic efficacy in mice infected with Echinococcus granulosus.
Ullio Gamboa GV; Pensel PE; Elissondo MC; Sanchez Bruni SF; Benoit JP; Palma SD; Allemandi DA
Exp Parasitol; 2019 Mar; 198():79-86. PubMed ID: 30769018
[TBL] [Abstract][Full Text] [Related]
14. Intra-cystic concentrations of albendazole-sulphoxide in human cystic echinococcosis: a systematic review and analysis of individual patient data.
Lötsch F; Naderer J; Skuhala T; Groger M; Auer H; Kaczirek K; Waneck F; Ramharter M
Parasitol Res; 2016 Aug; 115(8):2995-3001. PubMed ID: 27085708
[TBL] [Abstract][Full Text] [Related]
15. Long-term albendazole effectiveness for hepatic cystic echinococcosis.
Salinas JL; Vildozola Gonzales H; Astuvilca J; Arce-Villavicencio Y; Carbajal-Gonzalez D; Talledo L; Willig JH
Am J Trop Med Hyg; 2011 Dec; 85(6):1075-9. PubMed ID: 22144447
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy of albendazole chitosan microspheres against Echinococcus granulosus infection in mice].
Liang W; Wang XC; Wu XW; Zhang SJ; Sun H; Ma X; Peng XY
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2014 Jun; 32(3):188-92. PubMed ID: 25223052
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of preoperative albendazole use according to months in hydatid cyst of the liver.
Bildik N; Cevik A; Altintaş M; Ekinci H; Canberk M; Gülmen M
J Clin Gastroenterol; 2007 Mar; 41(3):312-6. PubMed ID: 17426473
[TBL] [Abstract][Full Text] [Related]
18. [Adverse effects of longterm, continual administration of high doses of albendazole in the treatment of echinococcal disease].
Jevtić M; Mikić D; Arsić-Komljenović G; Stanković N; Ristanović E; Sjenicić G; Janićijević-Hudomal S
Vojnosanit Pregl; 2008 Jul; 65(7):539-44. PubMed ID: 18700464
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the efficacy of albendazole sulfoxide (ABZ-SO)-loaded chitosan-PLGA nanoparticles in the treatment of cystic echinococcosis in laboratory mice.
Darvishi MM; Moazeni M; Alizadeh M; Abedi M; Tamaddon AM
Parasitol Res; 2020 Dec; 119(12):4233-4241. PubMed ID: 32996050
[TBL] [Abstract][Full Text] [Related]
20. Continuous long-term albendazole therapy in intraabdominal cystic echinococcosis.
Liu Y; Wang X; Wu J
Chin Med J (Engl); 2000 Sep; 113(9):827-32. PubMed ID: 11776080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
